LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
Integrin α11, a stromal collagen receptor, promotes tumor growth and metastasis of non-small cell lung cancer (NSCLC) and is associated with the regulation of collagen stiffness in the tumor stroma. We have previously reported that lysyl oxidase like-1 (LOXL1), a matrix cross-linking enzyme...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-05-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/11/5/705 |
| _version_ | 1797726294272638976 |
|---|---|
| author | Cédric Zeltz Elena Pasko Thomas R. Cox Roya Navab Ming-Sound Tsao |
| author_facet | Cédric Zeltz Elena Pasko Thomas R. Cox Roya Navab Ming-Sound Tsao |
| author_sort | Cédric Zeltz |
| collection | DOAJ |
| description | Integrin α11, a stromal collagen receptor, promotes tumor growth and metastasis of non-small cell lung cancer (NSCLC) and is associated with the regulation of collagen stiffness in the tumor stroma. We have previously reported that lysyl oxidase like-1 (LOXL1), a matrix cross-linking enzyme, is down-regulated in integrin α11-deficient mice. In the present study, we investigated the relationship between LOXL1 and integrin α11, and the role of LOXL1 in NSCLC tumorigenicity. Our results show that the expression of LOXL1 and integrin α11 was correlated in three lung adenocarcinoma patient datasets and that integrin α11 indeed regulated LOXL1 expression in stromal cells. Using cancer-associated fibroblast (CAF) with either a knockdown or overexpression of LOXL1, we demonstrated a role for LOXL1 in collagen matrix remodeling and collagen fiber alignment in vitro and in vivo in a NSCLC xenograft model. As a consequence of collagen reorganization in NSCLC tumor stroma, we showed that LOXL1 supported tumor growth and progression. Our findings demonstrate that stromal LOXL1, under regulation of integrin α11, is a determinant factor of NSCLC tumorigenesis and may be an interesting target in this disease. |
| first_indexed | 2024-03-12T10:43:32Z |
| format | Article |
| id | doaj.art-5d9997e7ef26444ebbbaee1ec7474442 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T10:43:32Z |
| publishDate | 2019-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-5d9997e7ef26444ebbbaee1ec74744422023-09-02T07:47:41ZengMDPI AGCancers2072-66942019-05-0111570510.3390/cancers11050705cancers11050705LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer TumorigenicityCédric Zeltz0Elena Pasko1Thomas R. Cox2Roya Navab3Ming-Sound Tsao4Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, CanadaPrincess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, CanadaThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, 370 Victoria St, Darlinghurst, Sydney, NSW 2010, AustraliaPrincess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, CanadaPrincess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, CanadaIntegrin α11, a stromal collagen receptor, promotes tumor growth and metastasis of non-small cell lung cancer (NSCLC) and is associated with the regulation of collagen stiffness in the tumor stroma. We have previously reported that lysyl oxidase like-1 (LOXL1), a matrix cross-linking enzyme, is down-regulated in integrin α11-deficient mice. In the present study, we investigated the relationship between LOXL1 and integrin α11, and the role of LOXL1 in NSCLC tumorigenicity. Our results show that the expression of LOXL1 and integrin α11 was correlated in three lung adenocarcinoma patient datasets and that integrin α11 indeed regulated LOXL1 expression in stromal cells. Using cancer-associated fibroblast (CAF) with either a knockdown or overexpression of LOXL1, we demonstrated a role for LOXL1 in collagen matrix remodeling and collagen fiber alignment in vitro and in vivo in a NSCLC xenograft model. As a consequence of collagen reorganization in NSCLC tumor stroma, we showed that LOXL1 supported tumor growth and progression. Our findings demonstrate that stromal LOXL1, under regulation of integrin α11, is a determinant factor of NSCLC tumorigenesis and may be an interesting target in this disease.https://www.mdpi.com/2072-6694/11/5/705lysyl oxidaseintegrin α11lung adenocarcinomamatrix cross-linkingtumor progression |
| spellingShingle | Cédric Zeltz Elena Pasko Thomas R. Cox Roya Navab Ming-Sound Tsao LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity Cancers lysyl oxidase integrin α11 lung adenocarcinoma matrix cross-linking tumor progression |
| title | LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity |
| title_full | LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity |
| title_fullStr | LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity |
| title_full_unstemmed | LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity |
| title_short | LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity |
| title_sort | loxl1 is regulated by integrin α11 and promotes non small cell lung cancer tumorigenicity |
| topic | lysyl oxidase integrin α11 lung adenocarcinoma matrix cross-linking tumor progression |
| url | https://www.mdpi.com/2072-6694/11/5/705 |
| work_keys_str_mv | AT cedriczeltz loxl1isregulatedbyintegrina11andpromotesnonsmallcelllungcancertumorigenicity AT elenapasko loxl1isregulatedbyintegrina11andpromotesnonsmallcelllungcancertumorigenicity AT thomasrcox loxl1isregulatedbyintegrina11andpromotesnonsmallcelllungcancertumorigenicity AT royanavab loxl1isregulatedbyintegrina11andpromotesnonsmallcelllungcancertumorigenicity AT mingsoundtsao loxl1isregulatedbyintegrina11andpromotesnonsmallcelllungcancertumorigenicity |